on Neurocare Group
Neurocare Group Announces Kevin Reeder as New CFO
Neurocare Group AG, a platform focused on mental health and performance, has appointed Kevin Reeder as Chief Financial Officer, effective January 1, 2025. Previously, Reeder was the CEO of the venture capital firm bm|t, a major investor in neurocare. His career spans international investment management, including roles at INVESCO, Silvergate Capital, and M-KOPA in Africa.
Reeder joined neurocare's board in 2021, influencing fundraising and strategic direction. He leaves the board to focus on CFO duties, aimed at enhancing the company's financial strategy and growth. Tristan de Boysson, Supervisory Board Chairman, praised Reeder's leadership and knowledge of neurocare's objectives.
Founder and CEO Thomas Mechtersheimer expressed confidence in Reeder's potential to accelerate the company's growth. Reeder acknowledged his new role with enthusiasm, highlighting the company's commitment to advancing mental health solutions.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Neurocare Group news